Arc-1

The tirzepatide price needs one answer

Arc-1's semaglutide page advertises treatment starting at $199.99 a month. Its dose options show $199.99 for 0.5 mg, $249.99 for 1 mg and $549.99 for 2.5 mg. The first two figures are not prices for every dose.

Tirzepatide is harder to budget. The page says $149 a month, while its product options list $199.99 for 2.5 mg, $249.99 for 5 mg and $399.99 for 7.5 mg. The homepage also starts tirzepatide at $199.99. We would not choose the lowest figure and call the discrepancy settled.

Get the charge and supplied quantity for the actual prescription together. A dose label does not establish how many injections arrive, and a monthly headline does not prove a calendar-month refill. Our billing-period guide explains why that distinction changes a treatment budget.

Checkout comes before the medical decision

The semaglutide page directs buyers to complete checkout, finish the intake form and then await professional approval. It advertises a $0 consultation fee and free shipping. Paying for an order is therefore not the same as receiving a prescription.

Arc-1's process page describes practitioner review, with chat, phone or video if clarification is needed, followed by approval and order processing. It does not promise every buyer a scheduled video appointment or a particular response time.

We would settle what happens to the payment if treatment is declined before following that sequence. The pages reviewed do not establish a medication-specific refusal refund, a guaranteed lab budget or a fixed clinical follow-up schedule. Free consultation is useful only if the care arrangements suit the prescription.

A company name does not identify the dispensing pharmacy

The terms identify Arc-1 Metrics, PLLC, with a Las Vegas address. That gives the purchase a named business contact; it does not identify the dispensing facility or establish an individual clinician's authority to treat someone in their state.

The founder page names Dr. Todd Stearns and describes an obstetrics-and-gynecology background. It uses both MD and DO degree labels, so his credentials need an independent check. A named founder does not establish who will treat you.

The product pages advertise licensed pharmacies and a physician network, but no assigned dispensing branch was established. A storefront vendor field is not a prescription label. Ask for the facility's legal name and location, then use our pharmacy verification guide. A certification badge does not answer that assignment question.

The guarantee has eligibility conditions

The refund policy allows a return request within 30 days after receipt, subject to unused condition, original packaging and approval. It excludes sale items and several product categories. Approved refunds are described as taking six to eight weeks.

That is a retail return policy, not a clear promise that a prescribed injection can be returned after use. We would ask how it applies to the selected medicine and what happens before dispensing. Do not let the satisfaction badge substitute for that answer.

Establish whether the selected order will renew before you buy. No prescription-specific renewal or cancellation cutoff was established from these pages. Our cancellation guide separates stopping another charge from recovering one already paid.

Check the product's exclusions, not one nationwide claim

Semaglutide excludes Arkansas, Indiana, Minnesota, Puerto Rico and South Carolina. Tirzepatide excludes California, Arkansas, Indiana, Minnesota and South Carolina. Those are different product lists, not proof that every other location or every patient qualifies.

Our choice would depend on a written offer that reconciles those restrictions with the exact preparation, price, supply and follow-up. Until then, Arc-1 offers a route to investigate, but too many purchase terms remain open for an unqualified recommendation.